Clinical Trial

Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheters

Study acronym: CHG-port
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections". These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.
Trial Details
NCT Number NCT06720064
Lead Sponsor Dokuz Eylul University
Collaborators: Afyonkarahisar Health Sciences University
Conditions Pediatric Cancer
Enrollment 40 participants
Start Date 2024-05-07
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-06